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Abstract In humans, partial-thickness cartilage lesions
frequently result in premature osteoarthritis. While rabbits
often are used as a model for partial-thickness cartilage
lesions, the natural course of cartilage surrounding such a
lesion is largely unknown. We developed a rabbit model
of a chronic partial-thickness cartilage defect and asked
whether these defects led to (1) deterioration of sur-
rounding cartilage macroscopically and microscopically
(increased Mankin score) and (2) disturbances in proteo-
glycan metabolism. In 55 rabbits, we created a 4-mm-
diameter partial-thickness cartilage defect on one medial
femoral condyle. The surrounding cartilage was charac-
terized during the course of 26 weeks. Contralateral knees
were sham-operated. In experimental knees, we found
cartilage softening and fibrillation at 13 and 26 weeks.
High Mankin scores observed at 1 week were partially
restored at 13 weeks but worsened later and were most
pronounced at 26 weeks. Mankin scores in the experi-
mental groups were worse at 1 and 26 weeks when
compared with the sham groups. Mankin scores at
26 weeks improved compared with 1 week in the sham
groups. Disturbances in proteoglycan metabolism were less
evident. In this rabbit model, a partial-thickness cartilage
lesion resulted in early markers of degenerative changes
resembling the human situation.
Introduction
Clinically, preventing joint degeneration is an important
rationale for repairing cartilage defects. Early diagnosis
and treatment of patients are recommended to prevent
progression to advanced osteoarthritis (OA). However,
most chondral defects are not symptomatic [5, 9] and
therefore exist for some time before they are treated. Fur-
thermore, the period of preoperative symptoms before
repair of the chondral defect often is extended. In our
clinic, the mean duration of symptoms before a defect was
treated was 29 months (range, 4–48 months) and
23 months (range, 3–48 months) for perichondrium trans-
plantation and open de´bridement and drilling, respectively
[2]. In one study, the mean duration of symptoms for
treating osteochondritis dissecans by autologous chondro-
cyte transplantation was 7.8 years (range, 0.1–36 years)
[25]. The extended duration between the occurrence of a
cartilage defect and its treatment in humans will likely
negatively influence the outcome of cartilage repair owing
to changes in joint homeostasis [27]. In contrast to the
human setting, in some animal studies, the cartilage lesions
were treated immediately after creation of the defect
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[7, 28]. The discrepancies between successfully tested
cartilage repair techniques in animals and the less favorable
outcomes in patients could be explained by the chronic
disturbances in human joint homeostasis relating to the
delay in treatment [2, 3, 13]. Therefore, an animal model
that better reflects the clinical situation, including an
extended period of preoperative cartilage damage [27],
would be better suited for evaluating experimental cartilage
repair techniques.
Full-thickness cartilage defects smaller than 3 mm in
diameter in a rabbit model reportedly regenerate sponta-
neously [23]. However, few studies have focused on
alterations in cartilage surrounding a partial-thickness
articular cartilage defect. Lu et al. [18] reported ongoing
degeneration of cartilage surrounding the defect in a sheep
model during the course of 52 weeks. Because rabbits often
are used as a model to test novel cartilage repair techniques,
Hunziker and Quinn [14] reported a considerable number of
chondrocytes were lost from cartilage adjacent to surgically
created partial-thickness articular cartilage defects, whereas
the synthetic activity of the remaining chondrocytes
remained unchanged. However, those authors created car-
tilage lesions with a width of 1 mm, which we believe is too
small for testing current cartilage repair techniques.
We describe a rabbit model in which chronic partial-
thickness articular cartilage defects were created with a
diameter of 4 mm. We asked whether these lesions led to
(1) deterioration of surrounding cartilage macroscopically
(loss of glossy appearance) and microscopically (increased
Mankin scores) and (2) disturbances in proteoglycan (PG)
metabolism (increase in PG synthesis rate and inability of
the cartilage matrix to retain newly synthesized PGs)
reflecting degenerating articular cartilage.
Materials and Methods
We followed macroscopic, histologic, and biochemical
changes during the course of 26 weeks to reflect degener-
ative changes in articular cartilage surrounding 4-mm
defects created on the medial femoral condyles of 55
3-month-old New Zealand White rabbits (females; average
weight, 2.5 kg; range, 1.5–3.0 kg). Contralateral knees
were sham-operated. From previous experiments and the
literature [21, 27], the sample size was determined based
on a difference of 1.5 points in the Mankin score (as
described by Mankin et al. [19]) using the power analysis
of Sachs [26], with a power of 80%, two-tailed, and a
confidence interval of 95%. This resulted in a minimum of
five knees per group for histologic evaluation. For analysis
of early changes in PG synthesis rate and ability of the
cartilage matrix to retain newly synthesized PGs, 12 knees
per group for each followup were chosen [21]. Two rabbits
were excluded from analysis; one rabbit died of pneumonia
and the second had a knee infection. One sample was lost
(Table 1). The experiments were conducted following the
national and European guidelines for animal experiments.
The Maastricht University Committee for Animal Experi-
ments approved all experimental protocols.
Preoperatively, each rabbit was fasted for 12 hours.
General anesthesia was induced by intramuscular injection
of 35 mg ketamine hydrochloride per kg body weight and
5 mg xylazine per kg and maintained throughout the sur-
gical procedure by administration of 2% halothane and a
mixture of oxygen and nitrous oxide delivered by an
automatic ventilator using a specially designed mask.
Preoperatively, all rabbits received an intramuscular
injection of 10 mg ceftiofur per kg. Arthrotomy of the
tibia-femoral articulation was performed through a medial
longitudinal parapatellar incision. The patella was dislo-
cated laterally to expose the surface of the medial femoral
condyle. A 4-mm-diameter skin biopsy punch (KAI Europe
GmbH, Solingen, Germany) was used to circumscribe the
defect centered on the weightbearing part of the medial
femoral condyle. Noncalcified cartilage was removed from
the outlined defect using a scalpel (defect group) to create a
partial-thickness defect. Special care was taken to prevent
penetration of the subchondral bone. The contralateral
knees (sham group) received an arthrotomy followed by
lateral dislocation of the patella, as performed in the
experimental knees but without creation of a defect. At
the end of the procedure in the defect and the sham groups,
the patellae were relocated and the wound was closed in
layers. Postoperative pain relief was provided by
Table 1. Rabbit demographics
Followup (weeks) Number of rabbits Weight (kg)* Number of knees
Histology Biochemistry
Sham Defect Sham Defect
1 18 2.6 (0.12) 6 5 12 12
13 17 3.7 (0.46) 5 5 12 12
26 18 4.4 (0.44) 6 6 12 12
* Values are expressed as means, with standard deviations in parentheses.
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administering 50 lg buphenomorphine per kg at 2 hours
and 1 day. The rabbits were housed in a cage for 2 days,
after which they were allowed to have unlimited activity in
groups in a stable. They were fed a standard rabbit diet and
had water ad libitum. They were euthanized 1, 13, and
26 weeks after surgery with an overdose of pentobarbital.
For macroscopic purposes, the femoral condyles were
dissected and photographed. The lesions were evaluated for
whether they were healed, and cartilage of the medial
femoral condyles was examined for cartilage softness and
fibrillation (indicated by a loss of glossy appearance). Then
condyles were prepared either for histologic grading or for
determination of PG synthesis and PG retention capacity of
the cartilage surrounding the defects using [35S]sulfate
incorporation ex vivo.
For histologic analysis, condyles were fixed in a 10%
formalin solution for 5 days at 4 C. After decalcification
in a 10% EDTA solution, samples were dehydrated in a
series of increasing concentrations of ethanol and embed-
ded in 2-hydroxyethyl methacrylate (Technovit 7100;
Heraeus Kulzer GmbH, Wehrheim, Germany). Sections of
5 lm were cut along the midsagittal plane using a multi-
range microtome (LKB, Stockholm, Sweden) and stained
with thionine. All sections were viewed at the same time by
two individuals (EJJ, RK) who were blinded to group
assignment. The articular cartilage on the entire width of
the medial femoral condyle was evaluated using the his-
tologic and histochemical grading system of Mankin et al.
[19]. Lower scores indicate better histologic appearance.
For biochemical analysis, the cartilage was harvested
from the medial femoral condyles under aseptic conditions
and transferred to preweighed tubes containing 1 mL
medium (Dulbecco’s Modified Eagle’s Medium/Ham’s
F12 nutrient mix with GlutaMAX
TM
I; Invitrogen, Breda,
The Netherlands) supplemented with ascorbic acid 2-
phosphate (0.2 mmol/L; Sigma-Aldrich Chemie BV,
Zwijndrecht, The Netherlands), penicillin (100 U/mL),
streptomycin (100 lg/mL), and amphotericin (0.25 lg/
mL) (Invitrogen). In the defect group, the cartilage 2 to
3 mm proximal and distal of the created defect was dis-
sected. The medium was discarded and 500 lL medium
supplemented with 3.7 · 105 Bq Na235SO4 (Amersham
Biosciences Benelux, Roosendaal, The Netherlands)
([35S]sulfate medium) per mL was added. The samples
were incubated in a humidified CO2 incubator overnight.
The [35S]sulfate medium was removed and cartilage sam-
ples were washed for 10 minutes three times with 1 mL
sterile phosphate-buffered saline. One half of the samples
were used for analysis of the PG synthesis [16] and the
other half for analysis of the PG retention capacity. To
determine PG retention, cartilage samples were cultured
under normal conditions in the presence of 10% fetal
bovine serum for an additional 48 hours [24]. The cartilage
samples were completely digested in a solution containing
0.15 lg proteinase K (Merck-Europe BV, Amsterdam, The
Netherlands) per lL, 0.1 lg PG (A1 fraction isolated from
human articular cartilage) per lL, 50 mmol Tris–HCl (pH
7.9) per L, and 1 mmol CaCl2 (Merck-Europe BV) per L in
a shaking water bath at 56 C for 3 days. After centrifu-
gation at 3000 g for 5 minutes, the DNA content of the
supernatants was assessed using a commercially available
assay kit (CyQUANT1 DNA assay kit; Invitrogen)
according to the manufacturer’s instructions. In brief,
200 lL CyQUANT1 GR dye/cell lysis buffer was added to
each sample. An aliquot of each sample was incubated for
5 minutes at room temperature protected from light expo-
sure. The sample fluorescence was measured at 480-nm
excitation and 520-nm emission wavelengths. Fluorescence
measurements were compared with the values obtained
from a standard DNA curve, and the resulting DNA content
was normalized to the cartilage wet weight.
The remaining supernatant was supplemented with
cetylpyridinium chloride (Merck-Europe BV) and NaCl to
a final concentration of 0.5% (w/v) and 0.2 mol/L,
respectively. Samples were incubated at 37 C for 1 hour
to precipitate the glycosaminoglycans, which then were
centrifuged at 15,000 g for 5 minutes. The supernatants
were discarded and the pellets were washed once with
100 lL of a solution of 0.1% cetylpyridinium chloride in
0.2 mol NaCl per L and then dried. Pellets were dissolved
in 100 lL formic acid (Merck-Europe BV) at room tem-
perature for 24 hours. A 10-lL aliquot of each sample was
mixed with 2.5 mL Formula 989 scintillation fluid
(DuPont, Dordrecht, The Netherlands) and counted in a
liquid scintillation counter. The total [35S]sulfate incorpo-
ration of each cartilage sample was calculated using the
specific activity of the medium and was normalized to the
cartilage wet weight.
Data were not normally distributed and therefore were
analyzed using nonparametric tests. First, data were ana-
lyzed using the Kruskal-Wallis (nonparametric one-way
analysis of variance) and Friedman overall tests. Then, a
two-tailed Mann-Whitney U test was performed to com-
pare differences in Mankin score, including all its
individual parameters (structure, cells, matrix, tidemark)
and PG metabolism (PG synthesis and PG retention
capacity) between treated (having a previously created
cartilage lesion) and sham-treated knees. A p value less
than 0.05 was considered significant. All data were ana-
lyzed with SPSS Version 12.0.1 (SPSS Inc, Chicago, IL).
Results
The creation of partial-thickness articular cartilage lesions
resulted in changes suggesting early degeneration: cartilage
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softening and fibrillation, indicated by loss of glossy
appearance of the articular surface at 13 and 26 weeks.
These changes were confirmed by histologic analysis
(increased Mankin scores) and biochemical alterations
(changes in PG metabolism). At 1 week (Fig. 1A), the
cartilage surrounding the defect had a glossy, white,
smooth appearance, which disappeared at 13 (Fig. 1B) and
26 weeks (Fig. 1C). In addition, at 13 and 26 weeks, the
articular surface around the created lesion showed signs of
fibrillation. In the sham groups, no noticeable macroscopic
abnormalities were observed during the course of 26 weeks
(not shown), but histologic analysis revealed minor
degenerative changes (Fig. 2). We found higher Mankin
scores in the defect groups at 1 week (p = 0.030) and
26 weeks (p = 0.024) compared with the sham groups
(Fig. 3). At 1 week, the sham group (Fig. 2A–B) scored
better (p = 0.036) than the defect group (Fig. 2C–D) on the
structure parameter (1.0 versus 2.0 for the sham and defect
groups, respectively) (Table 2). Surface irregularities were
more pronounced in the defect group compared with the
sham group. Cartilage cellularity was similar between
sham and defect knees. In both groups, the matrix staining
was reduced compared with the lateral femoral condyle and
the tidemark integrity was disturbed. At 13 weeks, we
observed no differences between the groups. The articular
surface remained irregular, whereas cartilage cellularity
was normal in both groups. Reduced matrix staining and
tidemark abnormalities also were observed at 13 weeks
(Fig. 2E–H). At 26 weeks, the sham group scored better
than the defect group in the structure (p = 0.022), cells
(p = 0.022), and tidemark parameters (p = 0.027)
(Table 2). In the defect group (Fig. 2K–L), the surface
showed more clefts compared with the sham group
(Fig. 2I–J). We observed cell clusters embedded in slightly
stained matrix, whereas the tidemark integrity remained
disturbed. In the sham series, the histologic appearance of
the cartilage at 26 weeks improved (p = 0.005) compared
with 1 week (Fig. 3). The matrix (p = 0.004) and tidemark
parameters (p = 0.027) also were improved (Table 2). The
mean cartilage wet weights and DNA contents of defect-
and sham-treated knees were similar (Table 3).
Between 13 and 26 weeks, we found a decrease
(p = 0.045) in the PG retention capacity in defect-treated
knees. However, we observed no differences in cartilage
metabolism (PG synthesis and PG retention capacity)
between cartilage from defect- and sham-treated knees at 1,
13, and 26 weeks (Table 3).
Discussion
In humans, untreated articular cartilage lesions often pro-
gress toward premature OA. This rationale for recent trends
for early repair is to prevent the OA. Numerous novel
repair procedures have been and are being developed for
this purpose. Such procedures often are tested in animal
models usually in symptom-free joints, whereas isolated
lesions in patients can be present for a considerable time
before treatment occurs. The natural course of cartilage
surrounding an isolated cartilage lesion in the often-used
acute rabbit model is largely unknown and may not
resemble the clinical setting with chronic alterations.
Therefore, we evaluated the effect of the lesion with time
on the surrounding cartilage with regard to macroscopic
(softening and fibrillation), microscopic (increased Mankin
score), and biochemical (increased PG synthesis and
inability to retain newly synthesized PGs) parameters.
This study has two major limitations. First, while eco-
nomically and practically attractive, the rabbit model is not
an entirely suitable animal model to study articular carti-
lage repair procedures in preclinical studies [13]. Hunziker
[13] noted ‘‘...the matrix domain sustained and remodeled
by an individual cellular unit is, in the human, approxi-
mately 8 to 10 times larger than that in the rabbit.’’ This
likely would lead to substantial enhancement in the rabbit
to maintain surrounding cartilage compared with the
human. Nevertheless, the rabbit is probably the most often
used model for economic reasons and the literature con-
tains interpretations based on rabbit data. Although we
believe our delayed rabbit model better represents the
clinical situation, cartilage repair procedures using this
model should still be interpreted with caution before
Fig. 1A–C Representative photographs are shown of articular
surfaces at (A) 1 week, (B) 13 weeks, and (C) 26 weeks after
creating partial-thickness articular cartilage defects on rabbit medial
femoral condyles. Cartilage surrounding the defect had a glossy,
white, smooth appearance at 1 week, which disappeared during the
course of 26 weeks.
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proceeding to clinical studies. The second limitation is the
power of the study, which was sufficient for histologic
grading using the Mankin score but not sufficient for the
biochemical parameters studied. Thus, we can describe
only trends for the PG synthesis and the capacity of the
cartilage matrix to retain newly synthesized PGs.
In this model, partial-thickness articular cartilage lesions
with a 4-mm diameter did not heal during the course of
26 weeks and we found no signs of regeneration; these
lesions therefore represent critical-size defects. We
observed degenerative features macroscopically and
microscopically at 13 and 26 weeks around the cartilage
defects. Histologically, the degeneration observed 1 week
Fig. 2A–L Photomicrographs of sections are shown at (A–D)
1 week, (E–H) 13 weeks, and (I–L) 26 weeks. (A) A sham-treated
rabbit medial femoral condyle at 1 week followup (Stain, thionine;
original magnification, ·100); (B) an enlargement of the box in (A)
(Stain, thionine; original magnification, ·400); and (C) a condyle
with partial-thickness articular cartilage defect at 1 week followup are
shown (Stain, thionine; original magnification, ·100). The cartilage
defect (*) did not penetrate the subchondral bone (SB); (D) An
enlargement of the box in (C) is shown (Stain, thionine; original
magnification, ·400). A cluster formation (CF) can be seen. (E) A
sham-treated rabbit medial femoral condyle at 13 weeks followup
(Stain, thionine; original magnification, ·100); (F) an enlargement of
the box in (E) (Stain, thionine; original magnification, ·400); (G) a
condyle with a partial-thickness articular cartilage defect at 13 weeks
followup (Stain, thionine; original magnification, ·100); and (H) an
enlargement of the box in (G) are shown (Stain, thionine; original
magnification, ·400). (I) A sham-treated rabbit medial femoral
condyle at 26 weeks followup (Stain, thionine; original magnification,
·100); (J) an enlargement of the box in (I) (Stain, thionine; original
magnification, ·400); and (K) a condyle with partial-thickness
articular cartilage defect at 26 weeks followup are shown (Stain,
thionine; original magnification, ·100). The partial-thickness articular
cartilage defect was not healed at 26 weeks. Cartilage surrounding the
defect showed surface irregularities; (L) an enlargement of the box in
(K) is shown (Stain, thionine; original magnification, ·400). A cluster
formation (CF) can be seen. The arrows in (C), (G), and (K) indicate
the edge of the defect.
b
Fig. 3 A histogram shows the degree of degenerative changes (using
the Mankin score) in rabbit medial femoral condyles 1, 13, or
26 weeks postoperatively. Worse histologic appearances were
observed in the defect (COD) groups at 1 and 26 weeks when
compared with the sham groups. The key shows means and standard
deviations. * = significant at p \ 0.05.
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postoperatively was partially reversed at 13 weeks but then
tended to increase again from 13 to 26 weeks. We noted no
progressive cartilage degeneration (as reflected by the
Mankin scores) from 13 to 26 weeks. This probably is
attributable to the slow progression of the degenerative
process, as has been observed in other quadrupeds. In the
dog, severe degeneration is first evident 5 years after ini-
tiation of the process [4]. The time at which severe
degeneration occurs in rabbits is unknown.
The sham-treated knee showed articular cartilage
changes during the first weeks after the arthrotomy, which
can be explained by the effects of the operation (e.g., effect
of exposure of room air, stress of the sutures in the rela-
tively small joint [1, 8, 22, 30]). During the course of
26 weeks, the cartilage appeared to fully recover as
observed histologically. This suggests regeneration of the
mild changes in sham-operated knees, which may be
related to peculiarities of the rabbit model.
Cell density was diminished at the wound edge of the
cartilage defects as observed histologically. However, we
observed normal cellularity using biochemical measure-
ments. These findings were consistent with results
described by Hunziker and Quinn [14], who reported with
quantitative autoradiographic analysis chondrocytes within
100 lm of a partial-thickness defect had synthetic activity
similar to that of cells far from the lesion. Furthermore,
the DNA assay, although one of the best available yet,
may not be sensitive enough to detect the cell death
occurring in the edges of the cartilage defects. Therefore,
normal cellularity, or even increased cell numbers, in
remote areas might compensate for hypocellularity in the
wound edges.
Biochemically, cartilage from experimental knees did
not differ from cartilage in sham-treated knees, which
could indicate cartilage surrounding a partial-thickness
articular defect was biochemically normal. However, this is
in contrast to our histologic findings suggesting degenera-
tive changes during the course of 26 weeks after creating
the defect. We noted a nonsignificant trend toward per-
sistent loss in PG retention after creation of the defect and
this might have contributed to the observed histologic
degeneration. A possible explanation for this lack of dif-
ference is that in sham-treated knees persistent biochemical
alterations take place in the first weeks because of the
arthrotomy, as was observed histologically, and after
13 weeks because of alterations in joint homeostasis,
occurring before histologic changes in cartilage
degeneration.
Our model involves creation of one circumscribed par-
tial-thickness articular cartilage lesion without concomitant
injuries of the meniscus or anterior cruciate ligament. It has
advantages compared with other animal models: (1) when
similar diameters are used, the effect of cartilage repair
techniques can be monitored without the confounding
effects of other potential causes of cartilage degeneration;
(2) the operation is relatively simple and creates cir-
cumscribed cartilage lesions; (3) repair of these chronic
partial-thickness articular cartilage lesions occurs with
surrounding degeneration, which resembles the clinical
situation [9, 12, 17, 23, 29, 32]; and (4) cartilage lesions are
created on the medial femoral condyle, which is the most
commonly affected zone of articular cartilage damage
observed with arthroscopies in humans [6, 10, 11]. Existing
animal models intended to replicate human OA fail to
Table 2. Mankin scores [19] at the different followup times
Mankin parameter 1 Week 13 Weeks 26 Weeks
Sham Defect Sham Defect Sham Defect
Structure 1.0 (0.0) 2.0 (1.2) 1.2 (0.4) 1.8 (1.8) 1.0 (0.0) 2.8 (1.8)
Cells 0.0 (0.0) 0.8 (1.3) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 1.7 (1.4)
Matrix 2.0 (0.6) 1.6 (0.9) 0.8 (1.1) 1.2 (0.8) 0.3 (0.5) 1.2 (1.0)
Tidemark 0.8 (0.4) 1.0 (0.0) 0.6 (0.5) 1.0 (0.0) 0.2 (0.4) 0.8 (0.4)
Values are expressed as means, with standard deviations in parentheses.
Table 3. Data on metabolic properties of articular cartilage at the different followup times
Followup (weeks) Wet weight (lg) DNA content (ng/lg) PG synthesis (dpm/lg) PG retention capacity (dpm/lg)
Sham Defect Sham Defect Sham Defect Sham Defect
1 6.7 (3.6) 7.3 (5.0) 2.1 (1.9) 2.1 (1.4) 2646 (1961) 2615 (1959) 814 (504) 270 (110)
13 5.6 (3.2) 7.0 (2.9) 3.2 (2.7) 1.6 (0.5) 1915 (1560) 1237 (383) 423 (306) 295 (122)*
26 8.4 (2.6) 8.8 (4.8) 0.8 (0.3) 1.4 (1.1) 1039 (271) 1103 (590) 339 (223) 175 (90)*
Values are expressed as means, with standard deviations in parentheses; *significantly different at p \ 0.05; PG = proteoglycan.
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resemble the clinical situation of a focal cartilage lesion,
whereas the permanent trigger for degeneration will inter-
fere with attempts of cartilage repair or regeneration [15,
31]. Damaging articular cartilage, as described in the
groove model [20, 21], did not reflect a one-time trauma in
the clinical setting. Furthermore, it would be challenging to
reproduce exactly the same grooves in each animal as far as
depth and length. Penetration of the subchondral bone,
as described in the articular step-off model [17], allows
migration of mesenchymal stem cells influencing the repair
process. In addition, although these are models for an
advanced stage of OA, they are not expected to reflect the
altered matrix metabolism and articular cartilage degener-
ation surrounding a focal partial-thickness articular
cartilage lesion with time.
We report the evolution of cartilage changes surround-
ing a partial-thickness articular cartilage defect in a rabbit
model during the course of 26 weeks. We believe a
delayed treatment model is important when exploring
cartilage repair strategies to prevent degenerative changes.
Our data suggest a defect at least 13 weeks old most likely
resembles the clinical focal cartilage lesion that has failed
to heal after an initial remodeling process.
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